FDA labels for Wegovy and Rybelsus warn of severe gastrointestinal adverse reactions but dont mention gastroenteritis
Most patients experience some reduction in appetite and improvement in blood sugar control within the first 1-2 weeks
Katz BJ, Lee MS, Lincoff NS, Abel AS, Chowdhary S, Ellis BD, et al
Industry insiders and experts believe that Elli Lilly will be awarded regulatory approval, in the 2nd quarter of 2026, for the pill version of its blockbuster GLP-1 drugs
The weekly injections start at 0.25 milligrams of active ingredient semaglutide and gradually increase to the maintenance dose of 2.4 mg, according to Novo Nordisks website
Some individuals are slow responders and dont feel full effects until week 8-10